Literature DB >> 26404950

Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients.

Christian Klemann1, Arne Schröder1, Anika Dreier1, Nora Möhn1, Stephanie Dippel1, Thomas Winterberg1, Anne Wilde1, Yi Yu1, Anja Thorenz2, Faikah Gueler2, Anne Jörns3, Eva Tolosa4, Johannes Leonhardt5, Jan D Haas6, Immo Prinz6, Gertrud Vieten1, Claus Petersen1, Joachim F Kuebler7.   

Abstract

BACKGROUND & AIMS: Biliary atresia (BA) is a rare disease in infants, with unknown mechanisms of pathogenesis. It is characterized by hepatobiliary inflammatory, progressive destruction of the biliary system leading to liver fibrosis, and deterioration of liver function. Interleukin (IL) 17A promotes inflammatory and autoimmune processes. We studied the role of IL17A and cells that produce this cytokine in a mouse model of BA and in hepatic biopsy samples from infants with BA.
METHODS: We obtained peripheral blood and liver tissue specimens from 20 patients with BA, collected at the time of Kasai portoenterostomy, along with liver biopsies from infants without BA (controls). The tissue samples were analyzed by reverse transcription quantitative polymerase chain reaction (PCR), in situ PCR, and flow cytometry analyses. BA was induced in balb/cAnNCrl mice by rhesus rotavirus infection; uninfected mice were used as controls. Liver tissues were collected from mice and analyzed histologically and by reverse transcriptase PCR; leukocytes were isolated, stimulated, and analyzed by flow cytometry and PCR analyses. Some mice were given 3 intraperitoneal injections of a monoclonal antibody against IL17 or an isotype antibody (control).
RESULTS: Livers from rhesus rota virus-infected mice with BA had 7-fold more Il17a messenger RNA than control mice (P = .02). γδ T cells were the exclusive source of IL17; no T-helper 17 cells were detected in livers of mice with BA. The increased number of IL17a-positive γδ T cells liver tissues of mice with BA was associated with increased levels of IL17A, IL17F, retinoid-orphan-receptor C, C-C chemokine receptor 6, and the IL23 receptor. Mice that were developing BA and given antibodies against IL17 had lower levels of liver inflammation and mean serum levels of bilirubin than mice receiving control antibodies (191 μmol/L vs 78 μmol/L, P = .002). Liver tissues from patients with BA had 4.6-fold higher levels of IL17 messenger RNA than control liver tissues (P = .02).
CONCLUSIONS: In livers of mice with BA, γδ T cells produce IL17, which is required for inflammation and destruction of the biliary system. IL17 is up-regulated in liver tissues from patients with BA, compared with controls, and might serve as a therapeutic target.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL17−Producing γδ T Cells; Neonatal Immune System; Th17 Cell; Virus-Induced Autoimmunity

Mesh:

Substances:

Year:  2015        PMID: 26404950     DOI: 10.1053/j.gastro.2015.09.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

Review 1.  Biliary atresia: unity in diversity.

Authors:  Claus Petersen
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

2.  Preferential TNFα signaling via TNFR2 regulates epithelial injury and duct obstruction in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Tatsuki Mizuochi; Reena Mourya; Sridevi Gutta; Li Yang; Zhenhua Luo; Jorge A Bezerra
Journal:  JCI Insight       Date:  2017-03-09

3.  The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia.

Authors:  Celine S Lages; Julia Simmons; Avery Maddox; Keaton Jones; Rebekah Karns; Rachel Sheridan; Shiva Kumar Shanmukhappa; Sujit Mohanty; Matthew Kofron; Pierre Russo; Yui-Hsi Wang; Claire Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

Review 4.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

5.  Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Authors:  Dana Tedesco; Manoj Thapa; Chui Yoke Chin; Yong Ge; Minghao Gong; Jing Li; Sanjeev Gumber; Patrick Speck; Elizabeth J Elrod; Eileen M Burd; William H Kitchens; Joseph F Magliocca; Andrew B Adams; David S Weiss; Mansour Mohamadzadeh; Arash Grakoui
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682

6.  RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers.

Authors:  An Ceulemans; Stefaan Verhulst; Matthias Van Haele; Olivier Govaere; Juan-Jose Ventura; Leo A van Grunsven; Tania Roskams
Journal:  Cell Death Dis       Date:  2017-11-02       Impact factor: 8.469

7.  Conventional alpha beta (αβ) T cells do not contribute to acute intestinal ischemia-reperfusion injury in mice.

Authors:  Yi Yu; Xiaoyan Feng; Gertrud Vieten; Stephanie Dippel; Tawan Imvised; Faikah Gueler; Benno M Ure; Jochen F Kuebler; Christian Klemann
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

8.  Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway.

Authors:  Jie Wen; Ying Zhou; Jun Wang; Jie Chen; Wenbo Yan; Jin Wu; Junkai Yan; Kejun Zhou; Yongtao Xiao; Yang Wang; Qiang Xia; Wei Cai
Journal:  Cell Death Differ       Date:  2017-03-17       Impact factor: 15.828

Review 9.  Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.

Authors:  Feliciano Chanana Paquissi
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

Review 10.  The Role of γδ T Cells in Fibrotic Diseases.

Authors:  Ilan Bank
Journal:  Rambam Maimonides Med J       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.